AzTrials
AzTrials

Heart Rate MonitoringNCT07402148

Research Proposal on the Effects of Different Altitude Conditions on Human Time Perception.

An observational study of Heart Rate Monitoring, run by Qilu Hospital of Shandong University at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this observational study is to investigate human time perception ability for different time intervals (540 ms, 1080 ms, 1620 ms, 2160 ms, 5 s, 10 s, 20 s, 50 s) under conditions of varying altitudes (500 m, 1000 m, 1500 m, 2000 m, 2500 m, 3000 m). Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Heart Rate Monitoring
What is being tested?
high-altitude environment
How many people
46 participants
Where
1 siteChina
Study dates
10 Feb 2026to 30 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: This study recruited healthy adult volunteers who met the inclusion and exclusion criteria in a university in Shandong Province

Who may be able to join

  • Age 18-50 years;
  • Not taking any medication during the monitoring period;
  • No history of anemia;
  • Have lived in plain area for a long time, and have no history of traveling in high altitude area in recent two months;
  • May want to live in plateau in the future
  • Voluntarily participate in the study and sign the informed consent.

Who cannot join

  • All subjects were excluded from claustrophobia, schizophrenia, affective disorder, mental retardation and other serious mental disorders as well as major physical and nervous system diseases, and had not taken psychotropic drugs
  • -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Qilu Hospital of Shandong University

    Jinan, Shandong, 250012

    yanfei 言 Hu, +86 18560088001, 1069012334@qq.com

    飞 言 胡, 1069012334@qq.com

Other trials in China

About this study

Official title: Research Proposal on the Effects of Different Altitude Conditions on Human Time Perception

The aim of this observational study is to investigate human time perception ability for different time intervals (540 ms, 1080 ms, 1620 ms, 2160 ms, 5 s, 10 s, 20 s, 50 s) under conditions of varying altitudes (500 m, 1000 m, 1500 m, 2000 m, 2500 m, 3000 m). Specifically, a hypobaric chamber will be used to simulate the aforementioned altitudes, and temporal reproduction tasks with different standard durations will be conducted at each altitude. The time difference between the actual perceived duration and the target duration will be calculated to assess the level of time perception ability-with a smaller difference indicating stronger time perception ability.

At each altitude, participants' heart rate (HR) and oxygen saturation (SpO₂) will also be monitored to explore the correlation between physiological status and time perception ability under different altitude conditions.

Being tested
high-altitude environment
Keywords
different altitude conditions, vital signs, Time perception ability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • high-altitude environmentDiagnostic test

    A high-altitude simulation chamber is used to simulate the environmental conditions at different altitudes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Human time perception ability

    The time difference between the actual duration used and the target duration when performing temporal reproduction of the target time interval.

    Measured: six months

Secondary outcomes (2)
  1. heart rate

    The number of heartbeats per minute

    Measured: six months

  2. oxygen saturation

    The percentage of oxyhemoglobin (HbO₂) in the blood relative to the total concentration of all bindable hemoglobin (Hb + HbO₂)

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2026
  2. Study start10 Feb 2026 (estimated)
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
46 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07402148
Sponsor's protocol ID
KYLL-202503-033-2
Status last verified
Jan 2026
First submitted
27 Nov 2025
Last updated
11 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Heart Rate Monitoring, run by Qilu Hospital of Shandong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ma dedong (+86 18560082806, ma@qiluhuxi.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Human time perception ability (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in